Enhancing balance in multiple sclerosis with training plus electrical stimulation
Official title: Innovative Approaches to Enhance Balance and Neuroplasticity in Multiple Sclerosis: Evaluating the Combined Effects of Transcutaneous Spinal Cord Stimulation, Functional Electrical Stimulation, and Visual Feedback Balance Training
Run by University Health Network, Toronto · NCT07174973 · Data updated 2026-11-12
This trial will test whether adding leg muscle stimulation and/or noninvasive spinal stimulation to balance training helps adults with multiple sclerosis who have balance or walking trouble.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 24 (estimated) |
| Sponsor | University Health Network, Toronto Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Toronto, Ontario) |
| Status | Recruiting |
| Started | December 30, 2025 |
| Main results expected | September 30, 2028 |
| Study ends | December 30, 2028 |
| Registry record updated | March 16, 2026 |
| Trial ID | NCT07174973 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with a confirmed MS diagnosis who are 65 or younger, can walk at least 100 meters (with or without a device), and report balance problems in daily life are ideal candidates.
✕Probably not a fit
People with uncorrected vision problems, significant cognitive impairment, recent MS exacerbation, other neurological or orthopedic conditions affecting balance, or who cannot walk 100 meters are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, single-center interventional study will enroll up to 24 adults with MS and self-reported balance impairment and assign them to one of three groups: balance training only; balance training with functional electrical stimulation (FES); or balance training with FES plus transcutaneous spinal cord stimulation (TSCS). Participants complete 12 supervised training sessions over six weeks. FES delivers small pulses to leg muscles and TSCS delivers surface stimulation to modulate spinal circuits, and standardized protocols will be used across groups. Primary outcomes will examine balance, gait, mobility and safety to determine whether neuromodulation adds benefit beyond training alone.
Why it matters
Potential benefit: If successful, the approach could improve standing and walking balance, reduce fall risk, and increase daily independence for people with MS.
How similar studies have gone: Functional electrical stimulation has shown benefit for gait in prior MS studies, spinal stimulation is an emerging approach with preliminary promise, and combining these modalities with balance training is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Participants will be eligible if they meet the following conditions: * Confirmed diagnosis of Multiple Sclerosis (MS) according to the revised McDonald criteria * Age ≤ 65 years * Ability to walk at least 100 meters, with or without an assistive device, and without requiring rest * Self-reported perception of impaired balance during standing or walking in daily activities Exclusion Criteria: * Participants will be excluded if they present with any of the following: * Uncorrected visual problems * Cognitive impairment affecting comprehension of instructions or completion of self-administered outcome measures * Ongoing MS exacerbation or paroxysmal vertigo * Concurrent neurological or orthopedic conditions affecting balance * Recent participation in rehabilitation therapies (physical therapy, occupational therapy, or vestibular therapy) within one month prior to recruitment * Planned or recent injection of botulinum toxin to the legs during the intervention period * Peripheral nerve damage affecting the legs * Contraindications to electrical stimulation, including:implanted electronic device, active cancer or radiation treatment within the past 6 months, uncontrolled epilepsy, skin rash or open wound at electrode site, pregnancy, active deep vein thrombosis
Where it's running
-
Toronto Rehabilitation Institute-Lyndhurst Center
Toronto, Ontario, Canada Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tailored balance training for people with multiple sclerosis
This study tests whether balance training that is customized to each person’s difficulty and effort is feasible for people with MS in an inpatient setting.
-
Sensor-enabled ankle brace for gait and balance testing in adults
Researchers are testing a modified ankle brace with built-in sensors to see if it accurately measures gait and balance compared with standard equipment in healthy adults.
-
Spinal posture, mobility, and balance in people with multiple sclerosis
This study will test how spinal posture and mobility relate to balance in adults with relapsing-remitting MS.
-
Figure-of-8 Walking Test in Motoric Cognitive Risk Syndrome
This observational study tests whether the Figure-of-8 Walk Test is a reliable and valid way to measure dynamic balance and gait in people with Motoric Cognitive Risk Syndrome.
-
How doing a thinking task while walking affects balance and gait in Motoric Cognitive Risk Syndrome
This test will see if doing a thinking task while walking changes walking speed and balance in people aged 65 and older with Motoric Cognitive Risk Syndrome.
-
Remotely Delivered Pilates for MS: Walking, Balance, Fatigue, Mood and Quality of Life
A 16-week remote Pilates program will be tested to see if it helps walking, balance, fatigue, pain, mood, thinking, and quality of life for people with multiple sclerosis who can participate from home.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.